A Descriptive, Prospective, Longitudinal, Open-Label Study Assessing the Efficacy of Ustekinumab in Patients with Psoriatic Arthritis with Peripheral Involvement in Real-Life
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2018
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 16 Jun 2018 Results (n=66) presented at the 19th Annual Congress of the European League Against Rheumatism.
- 06 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism.